Explore a living cell in 3D without damaging it
Nanolive has raised €23M across 4 funding rounds from 3 investors, most recently a Series C round in Sep 2022. Based in Ecublens, Switzerland; founded 2013; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2022-09-20 | Series C | €2.2M | Innoviva,Taiwania Capital | View deal → |
| 2022-04-04 | Series C | €18M | Swisscom Ventures,Taiwania Capital | View deal → |
| 2016-10-01 | Early VC | €500k | Swisscom Ventures | View deal → |
| 2014-04-01 | Early VC | €2.5M | — | View deal → |
